NeurologyLive Peer Exchange


Oral Therapy Options for Relapsing-Remitting Multiple Sclerosis

November 23rd 2021

Recommendations to neurologists on appropriately prescribing and managing patients with relapsing-remitting multiple sclerosis using novel, oral therapies.

The Changing Landscape of Preventive Treatment of Migraine

November 19th 2021

Expert neurologists provide a discussion on current treatment options for migraine and review data from recent clinical trials.

Parkinson’s Disease On-Demand Morning Therapy

October 12th 2021

Experts discuss the causes, impact on quality of life, and the management of morning OFF episodes in Parkinson’s disease.

Optimal Management of Relapsing Multiple Sclerosis: Advanced Practice Providers Perspectives

August 20th 2021

Recommendations for selecting and sequencing therapies used to treat patients with relapsing multiple sclerosis.

Optimal Management of Relapsing Multiple Sclerosis

June 29th 2021

Fred D. Lublin, MD; Ravi Dukkipati, MD; Gavin Giovannoni, MD; and Lauren Gluck, MD explore several topics pertaining to the diagnosis and treatment of relapsing multiple sclerosis (MS), including current treatment options, therapy sequencing, and the future of MS management.

Recognizing and Managing Advanced Parkinson Disease

June 22nd 2021

Neurology experts discuss the diagnosis and treatment of advanced Parkinson disease.

Redefining Treatment Outcomes in Dravet Syndrome

June 7th 2021

Panelists discuss recommendations for the diagnosis, treatment, and management of patients with Dravet Syndrome.

Strategies in Treating Relapsing-Remitting Multiple Sclerosis

April 19th 2021

Recommendations for appropriate treatment selection and use of high efficacy therapies as treatment for relapsing-remitting multiple sclerosis.

The Changing Landscape in the Treatment of Spinal Muscular Atrophy

April 16th 2021

Crystal Proud, MD; Claudia Chiriboga, MD, MPH; Tom Crawford, MD; Basil Darras, MD; and Carolina Tesi Rocha, MD provide a discussion on the importance of early diagnosis and treatment of spinal muscular atrophy and consider data from recent clinical trials of disease-modifying therapy options.

Progress in the Treatment of Amyotrophic Lateral Sclerosis (ALS)

April 13th 2021

Richard S. Bedlack, MD, PhD, MS; Ammar Al-Chalabi, MB, ChB, PhD; Jinsy A. Andrews, MD, MSc; and Jeremy M. Schefner, MD, PhD discuss the current treatment landscape for amyotrophic lateral sclerosis (ALS) and provide insights into ongoing clinical trials and recent results.